The machinery of programmed cell death

Pharmacology and Therapeutics

Volumn 92, Issue 1, 2001, Pages 57-70

  Zimmermann, Katja C ^a   Bonzon, Christine ^a   Green, Douglas R ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Apoptosis; Caspases; Death receptor; Mitochondria

Indexed keywords

ASPARTIC ACID; CASPASE; CYSTEINE PROTEINASE; CYTOCHROME C; DNA; ENZYME; FAS ANTIGEN; LIGAND; PROCASPASE 3; PROCASPASE 8; PROCASPASE 9; PROTEASE ACTIVATING FACTOR 1; PROTEIN; PROTEIN BCL 2; PROTEIN BID; RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CATALYSIS; CELL FUNCTION; CELL LINE; CELL SIZE; CELL STRUCTURE; CELL SURVIVAL; CHROMATIN CONDENSATION; CYTOPLASM; DEVELOPMENT; DNA CLEAVAGE; ENZYME ACTIVATION; HOMEOSTASIS; MITOCHONDRION; MOLECULAR BIOLOGY; OLIGOMERIZATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN TRANSPORT; REGULATORY MECHANISM; STRESS;

EID: 0035676977     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(01)00159-0     Document Type: Review

References (106)

1. Enhanced and accelerated lymphoproliferation in Fas-null mice
2. Fas ligand mediates activation-induced cell death in human T lymphocytes
3. Human ICE/CED-3 protease nomenclature
4. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
5. Death receptors: Signaling and modulation
6. Apoptosis control by death and decoy receptors
7. Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells
8. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors
9. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
10. Fas modulation of apoptosis during negative selection of thymocytes
11. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development
12. Molecular cloning of the interleukin-1 beta converting enzyme
13. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
14. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95
15. Caspases: The executioners of apoptosis
16. Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes
17. Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis
18. Apoptosis. The little devil of death
19. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis
20. Evidence of a novel event during neuronal death: Development of competence-to-die in response to cytoplasmic cytochrome c
21. IAP family proteins - Suppressors of apoptosis
22. X-linked IAP is a direct inhibitor of cell-death proteases
23. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
24. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
25. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
26. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
27. DIABLO promotes apoptosis by removing MIHA/XIAP from processed caspase 9
28. Genes required for the engulfment of cell corpses during programmed cell death in Caenorhabditis elegans
29. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
30. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane
31. Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter
32. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant
33. Apoptotic pathways: Paper wraps stone blunts scissors
34. Mitochondria and apoptosis
35. Functional human corneal equivalents constructed from cell lines
36. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance
37. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis
38. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death
39. Differential requirement for caspase 9 in apoptotic pathways in vivo
40. The CARD domain: A new apoptotic signalling motif
41. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L)
42. ERICE, a novel FLICE-activatable caspase
43. Inhibition of death receptor signals by cellular FLIP
44. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
45. Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B
46. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
47. A role for Fas in negative selection of thymocytes in vivo
48. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
49. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis
50. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
51. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
52. Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis
53. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
54. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
55. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
56. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
57. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
58. Protease activation during apoptosis: Death by a thousand cuts?
59. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis
60. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
61. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity
62. Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus
63. Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketone
64. The Fas death factor
65. Caspases: Killer proteases
66. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen
67. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement
68. Caspase-9 and APAF-1 form an active holoenzyme
69. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis
70. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
71. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2
72. Implication of calpain in caspase activation during B cell clonal deletion
73. Two CD95 (APO-1/Fas) signaling pathways
74. The role of c-FLIP in modulation of CD95-induced apoptosis
75. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB
76. Properties of the caspases
77. Caspase-9 can be activated without proteolytic processing
78. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
79. A single BIR domain of XIAP sufficient for inhibiting caspases
80. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs
81. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes
82. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis
83. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors
84. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis
85. Inhibition of TNF-induced apoptosis by NF-kappa B
86. Characterization of seven murine caspase family members
87. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes
88. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally
89. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
90. A major role for the Fas pathway in acute graft-versus-host disease
91. Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: A (p20/p10)2 homodimer
92. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
93. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
94. Structure and mechanism of interleukin-1 beta converting enzyme
95. Suicidal tendencies: Apoptotic cell death by caspase family proteinases
96. The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease
97. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
98. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
99. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
100. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
101. Apaf1 is required for mitochondrial pathways of apoptosis and brain development
102. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme
103. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)
104. Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice
105. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
106. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9